11. Type II citrullinemia may also develop in people who had a liver disorder called neonatal cholestasis during infancy. 12. Citrin is associated with type II citrullinemia and neonatal intrahepatic cholestasis caused by citrin deficiency ( NICCD ). 13. This protein is associated with progressive familial intrahepatic cholestasis type 1 as well as benign recurrent intrahepatic cholestasis. 14. This protein is associated with progressive familial intrahepatic cholestasis type 1 as well as benign recurrent intrahepatic cholestasis . 15. Cholestasis , Stevens Johnson syndrome, and toxic epidermal necrolysis are some other rare side effects that may occur.16. Low levels of albumin tend to indicate a chronic condition, while it is normal in hepatitis and cholestasis . 17. A diameter of more than 8 mm is regarded as abnormal dilatation, and is a sign of cholestasis . 18. Mutations in this gene may result in progressive familial intrahepatic cholestasis type 1 and in benign recurrent intrahepatic cholestasis. 19. Mutations in this gene may result in progressive familial intrahepatic cholestasis type 1 and in benign recurrent intrahepatic cholestasis . 20. In the liver, the enlargement of hepatocytes due to fatty change may compress adjacent bile canaliculi, leading to cholestasis .